ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $303,669 | -28.3% | 16,300 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $423,474 | -1.0% | 16,300 | +9.4% | 0.00% | 0.0% |
Q1 2023 | $427,928 | +35.1% | 14,900 | +39.3% | 0.00% | 0.0% |
Q4 2022 | $316,720 | +118.4% | 10,700 | +75.4% | 0.00% | – |
Q3 2022 | $145,000 | +6.6% | 6,100 | 0.0% | 0.00% | – |
Q2 2022 | $136,000 | -11.1% | 6,100 | 0.0% | 0.00% | – |
Q1 2022 | $153,000 | -30.1% | 6,100 | 0.0% | 0.00% | – |
Q4 2021 | $219,000 | -67.4% | 6,100 | -61.4% | 0.00% | -100.0% |
Q3 2021 | $672,000 | -1.8% | 15,800 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $684,000 | +6.2% | 15,800 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $644,000 | -9.9% | 15,800 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $715,000 | +26.3% | 15,800 | -1.2% | 0.00% | +100.0% |
Q3 2020 | $566,000 | -6.3% | 16,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $604,000 | +30.5% | 16,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $463,000 | -44.2% | 16,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $830,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |